Antiretroviral activity from elderberry (Sambucus nigra L.) flowers against HIV-2 infection via reverse transcriptase inhibition: a viroinformatics study

Submitted: 4 November 2023
Accepted: 7 May 2024
Published: 13 June 2024
Abstract Views: 280
PDF: 79
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


HIV-2 infection is a unique concern with fewer cases than HIV-1, but it poses a high mortality rate due to its resistance to all HIV-1 antiretroviral treatments. This study focuses on one type of antiretroviral, reverse transcriptase (RT) inhibitors, as they play an important role in HIV-2 replication. The screening of potential HIV-2 antiretroviral candidates was carried out using compounds from elderberry (Sambucus nigra L.) flower extract. There is a lack of research on the antiviral potential of elderberry flower extracts, particularly in HIV-2; therefore, this study is important to explain the molecular mechanism underlying the potential of elderberry (Sambucus nigra L.) flower extracts to inhibit RT activity in HIV-2 through bioinformatics simulations. This study uses the in silico method, involving sample preparation in the database, drug-like molecular prediction through the server, molecular docking simulation, chemical bond interaction analysis, and three-dimensional structure visualization. Isorhamnetin has the most negative binding affinity of -9.9 kcal/mol compared to other compounds. It interacts with the HIV-2 RT domain at residues Trp4(B), Pro25(B), Asn137(B), Pro133(B), Gln23(B), Pro140(B), Leu21(B), Ile90(A), Thr131(B), Asn57(B), Arg22(B), and Glu89(A) with hydrophobic bond interactions. Hydrogen bond interactions are formed at the positions of Ser134(B), Gly141(B), and Thr88(A). Isorhamnetin from elderberry (Sambucus nigra L.) flower extract could be a potential HIV-2 antiretroviral candidate because it has the most negative binding affinity and the formation of hydrophobic hydrogen bond interactions on the RT domain.



PlumX Metrics


Download data is not yet available.


Chukwu CW, Fatmawati, Utoyo MI, et al. Fractional model of HIV transmission on workplace productivity using real data from Indonesia. Math Comput Simul 2023; doi: 10.1016/j.matcom.2023.11.014. DOI:
Ceccarelli G, Giovanetti M, Sagnelli C, et al. Human immunodeficiency virus type 2: the neglected threat. Pathogens 2021;10:1377. DOI:
Esbjörnsson J, Jansson M, Jespersen S, et al. HIV-2 as a model to identify a functional HIV cure. AIDS Res Ther 2019;16:24. DOI:
Izzah Z, Suprapti B, Asmarawati TP, et al. Antiretroviral adherence and treatment outcomes among people living with HIV at an Indonesian HIV clinic: a cross-sectional study. Pharm Pract 2023;22:1-14.
Megasari NLA, Wijaksana IKE. Factors affecting HIV viral load of antiretroviral therapy-experienced and naïve individuals residing in Bali, Indonesia. Malaysian J Med Heal Sci 2023;19:111-5.
Van der Loeff MFS. Epidemiology, natural history and treatment of HIV-2 infections. Glob HIV/AIDS Med 2008;637-47. DOI:
Nursalam N, Sukartini T, Misutarno M, Priyantini D. Adherence to antiretroviral therapy, CD4 count, viral load and opportunistic infections in people with HIV/AIDS: a cross-sectional study. J Ners 2024;19:88-94. DOI:
Arifin B, Rokhman MR, Zulkarnain Z, et al. The knowledge mapping of HIV/AIDS in Indonesians living on six major islands using the Indonesian version of the HIV-KQ-18 instrument. PLoS One 2023;18:e0293876. DOI:
Armini NKA, Nursalam N, Ikmala LS. Analysis of factors influencing health-related quality of life in HIV/AIDS patients. HIV AIDS Rev 2023;22:300-4. DOI:
Rohman R, Nursalam N, Sukartini T, et al. Development of a spiritual-based palliative care model for the quality of life of people with HIV/AIDS. Healthc Low-Resour S 2023;11:11737. DOI:
Moranguinho I, Taveira N, Bártolo I. Antiretroviral treatment of HIV-2 infection: available drugs, resistance pathways, and promising new compounds. Int J Mol Sci 2023:24:5905. DOI:
Umunnakwe CN, Duchon A, Nikolaitchik OA, et al. Specific guanosines in the HIV-2 leader RNA are essential for efficient viral genome packaging. J Mol Biol 2021;433:166718. DOI:
Boyer PL, Clark PK, Hughes SH. HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors. J Virol 2012;86:5885-94. DOI:
Młynarczyk K, Walkowiak-Tomczak D, Łysiak GP. Bioactive properties of Sambucus nigra L. as a functional ingredient for food and pharmaceutical industry. J Funct Foods 2018;40:377-90. DOI:
Mocanu ML, Amariei S. Elderberries-a source of bioactive compounds with antiviral action. Plants 2022;11:740. DOI:
Ferreira-Santos P, Badim H, et al. Chemical characterization of Sambucus nigra L. flowers aqueous extract and its biological implications. Biomolecules 2021;11:1222. DOI:
Haș IM, Teleky BE, Szabo K, et al. Bioactive potential of elderberry (Sambucus nigra L.): antioxidant, antimicrobial activity, bioaccessibility and prebiotic potential. Molecules 2023;28:3099. DOI:
Ansori ANM, Kharisma VD, Solikhah TI. Medicinal properties of Muntingia Calabura l.: a review. Res J Pharm Technol 2021;14:4509-12. DOI:
Dibha AF, Wahyuningsih S, Ansori ANM, et al. Utilization of secondary metabolites in Algae Kappaphycus alvarezii as a breast cancer drug with a computational method. Pharmacogn J 2022;14:536-43. DOI:
Kharisma VD, Ansori ANM, Widyananda MH, et al. Molecular simulation: the potency of conserved region on E6 HPV-16 as a binding target of black tea compounds against cervical cancer. Biochem Cell Arch 2020;20:2795-802.
Listiyani P, Kharisma VD, Ansori ANM, et al. In silico phytochemical compounds screening of allium sativum targeting the Mpro of SARS-CoV-2. Pharmacogn J 2022;14:604-9. DOI:
Maulani Wijaya R, Aldino Hafidzhah M, Dhea Kharisma V, et al. COVID-19 in silico drug with zingiber officinale natural product compound library targeting the Mpro protein. Makara J Sci 2021;25:162-71. DOI:
Antonius Y, Kharisma VD, Widyananda MH, et al. Prediction of aflatoxin-B1 (AFB1) molecular mechanism network and interaction to oncoproteins growth factor in hepatocellular carcinoma. J Pure Appl Microbiol 2022;16:1844-54. DOI:
Chandra A, Chaudhary M, Qamar I, et al. In silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase. J Biomol Struct Dyn 2022;40:6534-44. DOI:
Shah-abadi ME, Ariaei A, Moradi F, et al. In silico interactions of natural and synthetic compounds with key proteins involved in alzheimer’s disease: prospects for designing new therapeutics compound. Neurotox Res 2023;41:408-30. DOI:
Krihariyani D, Haryanto E, Sasongkowati R. In silico analysis of antiviral activity and pharmacokinetic prediction of brazilein sappan wood (Caesalpinia sappan L.) against SARS-CoV-2 spike glycoproteins. Indonesian J Med Lab Sci Technol 2021;3:26-37. DOI:
Porter RS, Bode RF. A Review of the antiviral properties of black elder (Sambucus nigra L.) products. Phyther Res 2017;31:533-54. DOI:
Mahboubi M. Sambucus nigra (black elder) as alternative treatment for cold and flu. Adv Tradit Med 2021;21:405-14. DOI:
Castillo-Maldonado I, Moreno-Altamirano MMB, Serrano-Gallardo LB. Anti-dengue serotype-2 activity effect of Sambucus nigra leaves-and flowers-derived compounds. Virol Res Rev 2017;1:1-5. DOI:
Singh J, Malik D, Raina A. Computational investigation for identification of potential phytochemicals and antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19. J Biomol Struct Dyn 2022;40:3492-507. DOI:
Khan I, Zaib S. Designing next-generation drug-like molecules for medicinal applications. Molecules 2023;28:1860. DOI:
Deshpande RR, Tiwari AP, Nyayanit N, Modak M. In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2. Eur J Pharmacol 2020;886:173430. DOI:
Moovarkumudalvan B, Geethakumari AM, Ramadoss R, et al. Structure-based virtual screening and functional validation of potential hit molecules targeting the SARS-CoV-2 main protease. Biomolecules 2022;12:1754. DOI:
Terefe EM, Ghosh A. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of phytochemicals isolated from croton dichogamus against the HIV-1 reverse transcriptase. Bioinform Biol Insights 2022;16:11779322221125605. DOI:
Kondratyev MS, Rudnev VR, Nikolsky KS, et al. In Silico study of the interactions of Anle138b isomer, an inhibitor of amyloid aggregation, with partner proteins. Int J Mol Sci 2022;23:16096. DOI:
Gurung AB, Ali MA, Elshikh MS, et al. An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 omicron inhibitors. Saudi J Biol Sci 2022;29:103297. DOI:
El Safadi Y, Vivet-Boudou V, Marquet R. HIV-1 reverse transcriptase inhibitors. Appl Microbiol Biotechnol 2007;75:723-37. DOI:

How to Cite

Zainul, R., Kharisma, V. D., Ciuputri, P., Ansori, A. N. M., Herdiansyah, M. A., Sahadewa, S., & Durry, F. D. (2024). Antiretroviral activity from elderberry (<i>Sambucus nigra</i> L.) flowers against HIV-2 infection via reverse transcriptase inhibition: a viroinformatics study. Healthcare in Low-Resource Settings.